HK1036406A1 - Use of macrolide compounds for the treatment of ards - Google Patents

Use of macrolide compounds for the treatment of ards

Info

Publication number
HK1036406A1
HK1036406A1 HK01107256A HK01107256A HK1036406A1 HK 1036406 A1 HK1036406 A1 HK 1036406A1 HK 01107256 A HK01107256 A HK 01107256A HK 01107256 A HK01107256 A HK 01107256A HK 1036406 A1 HK1036406 A1 HK 1036406A1
Authority
HK
Hong Kong
Prior art keywords
treatment
ards
macrolide compounds
compounds
macrolide
Prior art date
Application number
HK01107256A
Other languages
English (en)
Inventor
Tadatsura Koshika
Itsuo Nagatomi
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of HK1036406A1 publication Critical patent/HK1036406A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK01107256A 1998-03-06 2001-10-17 Use of macrolide compounds for the treatment of ards HK1036406A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPP2231A AUPP223198A0 (en) 1998-03-06 1998-03-06 New use
PCT/JP1999/001064 WO1999044597A2 (en) 1998-03-06 1999-03-04 Use of macrolide compounds for the treatment of ards

Publications (1)

Publication Number Publication Date
HK1036406A1 true HK1036406A1 (en) 2002-01-04

Family

ID=3806495

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01107256A HK1036406A1 (en) 1998-03-06 2001-10-17 Use of macrolide compounds for the treatment of ards

Country Status (15)

Country Link
US (1) US6333334B1 (ko)
EP (1) EP1059921B1 (ko)
JP (1) JP3367105B2 (ko)
KR (1) KR100395571B1 (ko)
CN (1) CN1133429C (ko)
AT (1) ATE244008T1 (ko)
AU (1) AUPP223198A0 (ko)
BR (1) BR9908796A (ko)
CA (1) CA2322027C (ko)
DE (1) DE69909257T2 (ko)
DK (1) DK1059921T3 (ko)
ES (1) ES2196840T3 (ko)
HK (1) HK1036406A1 (ko)
PT (1) PT1059921E (ko)
WO (1) WO1999044597A2 (ko)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070032853A1 (en) 2002-03-27 2007-02-08 Hossainy Syed F 40-O-(2-hydroxy)ethyl-rapamycin coated stent
US20050118344A1 (en) 2003-12-01 2005-06-02 Pacetti Stephen D. Temperature controlled crimping
PL2071917T3 (pl) * 2006-09-29 2013-04-30 Infa Sa System opakowaniowy dla kompozycji farmaceutycznych oraz zestaw do podawania dożylnego
JP2010514790A (ja) * 2006-12-28 2010-05-06 リメリック バイオファーマ， インコーポレイテッド 治療処置のための方法および組成物
EP2124898B1 (en) 2007-01-10 2013-08-14 Board of Regents, The University of Texas System Enhanced delivery of immunosuppressive drug compositions for pulmonary delivery
CN101011414B (zh) * 2007-01-29 2010-07-21 褚福明 一种肺脑合剂药物
CA2693338A1 (en) * 2007-07-31 2009-02-05 Limerick Biopharma, Inc. Phosphorylated pyrone analogs and methods
CN101810633B (zh) * 2010-03-31 2011-12-14 湖北丝宝药业有限公司 地红霉素在制备治疗慢性非感染性呼吸道疾病药物的用途
GB201212773D0 (en) * 2012-07-18 2012-08-29 Ucl Business Plc Vascular remodelling

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894366A (en) * 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
GB2248184A (en) * 1990-09-28 1992-04-01 Fujisawa Pharmaceutical Co New use of macrolide compounds for active oxygen-mediated diseases
CA2054983A1 (en) * 1990-11-08 1992-05-09 Sotoo Asakura Suspendible composition and process for preparing the same
AU8910891A (en) * 1990-11-20 1992-06-11 National Heart & Lung Institute, The Treatment of lung diseases
US5208241A (en) * 1991-09-09 1993-05-04 Merck & Co., Inc. N-heteroaryl, n-alkylheteroaryl, n-alkenylheteroaryl and n-alkynylheteroarylmacrolides having immunosuppressive activity
GB9218027D0 (en) * 1992-08-25 1992-10-14 Fisons Plc Novel method of treatment
US5290689A (en) * 1992-09-28 1994-03-01 Merck & Co., Inc. New cyclic FR-900520 microbial biotransformation agent

Also Published As

Publication number Publication date
CA2322027A1 (en) 1999-09-10
CN1133429C (zh) 2004-01-07
CA2322027C (en) 2009-05-12
KR20010041046A (ko) 2001-05-15
AUPP223198A0 (en) 1998-04-02
EP1059921A2 (en) 2000-12-20
BR9908796A (pt) 2000-10-31
DK1059921T3 (da) 2003-10-27
CN1292695A (zh) 2001-04-25
EP1059921B1 (en) 2003-07-02
JP3367105B2 (ja) 2003-01-14
DE69909257T2 (de) 2004-02-19
PT1059921E (pt) 2003-11-28
US6333334B1 (en) 2001-12-25
DE69909257D1 (de) 2003-08-07
WO1999044597A2 (en) 1999-09-10
ATE244008T1 (de) 2003-07-15
JP2001520682A (ja) 2001-10-30
ES2196840T3 (es) 2003-12-16
KR100395571B1 (ko) 2003-08-21
WO1999044597A3 (en) 1999-12-29

Similar Documents

Publication Publication Date Title
HK1031869A1 (en) 1-Ä(1-Substituted-4-piperidinyl)methylÜ-4-piperdine derivatives, process for producing the same, medicinal compositions containing the same and intermediates of these compounds.
TWI224595B (en) New benzazepine derivatives, drugs containing these and use of the same for producing drugs
TR200001203T2 (tr) Yeni birleşik maddeler
HUP0103147A3 (en) Pharmaceutical composition comprising glp1 and their use for the treatment of functional dyspepsia and/or irritable bowel syndrome
PL349028A1 (en) Cancer treatment composition and method using natural plant essential oils
NZ507350A (en) Semi-synthetic ecteinascidins and use in treatment of tumors
DK1056454T3 (da) Anvendelse af makrolidforbindelser til behandling af glaukom
IL145213A0 (en) Polyurethane solutions containing allkoxysilane structural units
WO2001035950A3 (en) Benzamide therapeutics and methods for treating inflammatory bowel disease
AP1424A (en) 2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole in combination with estrogens.
PL323490A1 (en) Tetralinic compounds exibiting acitity against multgiple-drug refractoriness
ATE180781T1 (de) Kristallines tiagabinehydrochlorid-monohydrat, seine herstellung und verwendung
HK1036406A1 (en) Use of macrolide compounds for the treatment of ards
HUP0003219A3 (en) Phthalazine derivatives, process for producing them and pharmaceutical compositions containing them and use of the compounds for producing pharmaceutical compositions useful for treating erectile dysfunction
MXPA00007394A (es) Compuestos, composiciones y metodos para tratar o evitar infeccion de neumovirus y enfermedades asociadas.
MXPA03000606A (es) Derivados de benzofurano y su uso como agentes antibacterianos.
AU3600199A (en) A pharmaceutical composition containing ezrin mutated on tyrosine 353
MXPA04000272A (es) Derivados de 4-aminociclohexanol sustituidos.
ZA912363B (en) Benzoxazine derivatives,process for their preparation and their use for the treatment or for the prophylaxis of deseases
WO2001035951A3 (en) Aryl nitrone therapeutics and methods for treating inflammatory bowel disease
WO2000074665A3 (en) New use of macrolide compounds for inducing chondrogenic differentiation
ZA971036B (en) Pharmaceutical compositions for the prevention or treatment of retrovirus infections.
GB9814269D0 (en) 9a-Aza-3-ketolides, compositions containing such compounds and methods of treatment
ZA983753B (en) Medicinal composition for treatment of burns, cuts and like wounds.
EE05184B1 (et) Kaloporosiidi derivaadid, nende valmistamine ja kasutamine ravimina, neid sisaldavad ravimid ning mikroorganismi Gloeoporus dichrous (Fr.:Fr.) tvi ST001714 (DSM 13784)

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20110304